Literature DB >> 25361556

Lack of knowledge about mother-to-child HIV transmission prevention in pregnant women at Tijuana General Hospital, Baja California, Mexico.

Chandra M Becka1, Enrique Chacón-Cruz2, Maria Rosario Araneta3, Rolando M Viani4.   

Abstract

The objective of this study was to identify determinants of human immunodeficiency virus (HIV) knowledge regarding mother-to-child transmission (MTCT) among pregnant women at Tijuana General Hospital, Baja California, Mexico. Between March and November 2003, patients from the prenatal care (n = 1294) and labor and delivery (L&D) units (n = 495) participated in a cross-sectional study to measure HIV knowledge. Less than one-third (30%) knew that HIV could be transmitted to a child during delivery, and 36% knew that HIV could be transmitted by breast-feeding. Only 27% knew that an MTCT could be prevented. Prenatal patients were more likely to know that MTCT was preventable (prenatal: 31% versus L&D 25%; P = .02). Logistic regression indicated that prenatal patients (odds ratio = 1.49, confidence interval 1.07-2.07) were more likely to know that HIV could be transmitted through breast-feeding. Overall, both groups had poor knowledge regarding MTCT of HIV.
© The Author(s) 2014.

Entities:  

Keywords:  AIDS; HIV transmission knowledge; Mexico; mother-to-child HIV transmission; prevention

Mesh:

Year:  2014        PMID: 25361556     DOI: 10.1177/2325957414557262

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  1 in total

1.  Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.

Authors:  Alicia Ramírez-Ramírez; Elías Sánchez-Serrano; Giselle Loaiza-Flores; Noemí Plazola-Camacho; Rosa Georgina Rodríguez-Delgado; Ricardo Figueroa-Damián; Mauricio Domínguez-Castro; Margarita López-Martínez; Zayra Flores-García; Jessica Hernández-Pineda
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.